IL-12 vaccine (Etubics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIL-12 vaccine (Etubics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vectorVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionInterleukin-12 modulators

TargetsInterleukin-12

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEtubics Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEtubics Corp

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A